当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 2018年第7期
编号:13235791
动脉血乳酸与急性ST段抬高型心肌梗死临床相关性分析(3)
http://www.100md.com 2018年3月5日 《中西医结合心血管病电子杂志》 2018年第7期
     [3]Geppert A,Dorninger A,Delle-Karth G,et al.Plasma concentrations of interleukin-6, organ failure,vasopressor support,and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction[J].Crit Care Med,2006,34(8):2035-2042

    [4]中華医学会心血管病学分会.2010急性ST段抬高型心肌梗死诊断及治疗指南.中华心血管病杂志[J].2010,38(8):675-690.

    [5]Levy B.Lactate and shock state: the metabolic view[J].Curr Opin Crit Care,2006,12(4):315-321.

    [6]Leverve XM,Mustafa I. Lactate: a key metabolite in the intracellular metabolic interplay[J].Critical Care 2002,6(4):284-285.

    [7]Nichol AD,Egi M, Pettila V, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study[J].Crit Care,2010,14(1):R25.

    [8]胡大一,黄 俊,马长生,等.心血管内科学高级教程[M].人民军医出版社.2015,10.146-150.

    [9]Valente S,Lazzeri C,Vecchio S,et al.Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock[J].Int J Cardiol,2007,114(2):176-182.

    本文编辑:吴宏艳, 百拇医药(薛明 周文博)
上一页1 2 3